Sign inGet started

Murugan Amar

Insider CIK 1809916 · ATRA SVP, GC & Secretary · SLRN Chief Legal Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SLRN ACELYRIN, Inc. D To issuer deriv2025-05-212025-05-23525,000— $00SEC↗
SLRN ACELYRIN, Inc. D To issuer2025-05-212025-05-23121,587— $00SEC↗
SLRN ACELYRIN, Inc. S Sale2025-03-172025-03-193,913$2.74 $10.7K121,587SEC↗
SLRN ACELYRIN, Inc. A Award2025-01-232025-01-24125,000— $0125,500SEC↗
SLRN ACELYRIN, Inc. A Award deriv2024-11-252024-11-27525,000— $0525,000SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2024-08-162024-08-20192$6.63 $1.3K26,916SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2024-08-162024-08-2089$6.63 $59026,827SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2024-08-162024-08-20877$6.63 $5.8K27,108SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2024-05-162024-05-2032,401$0.62 $20.1K695,120SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2024-03-042024-03-0610,044$0.72 $7.2K727,521SEC↗
ATRA Atara Biotherapeutics, Inc A Award2024-01-082024-01-09475,000— $0737,565SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2023-11-162023-11-208,307$0.39 $3.2K257,084SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2023-08-162023-08-183,622$1.65 $6.0K265,391SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2023-08-162023-08-185,050$1.65 $8.3K269,013SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2023-05-162023-05-187,404$2.04 $15.1K271,930SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2023-05-162023-05-18985$2.04 $2.0K270,945SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2023-03-022023-03-064,221$3.63 $15.3K279,334SEC↗
ATRA Atara Biotherapeutics, Inc A Award deriv2023-03-012023-03-03349,593— $0349,593SEC↗
ATRA Atara Biotherapeutics, Inc A Award2023-03-012023-03-03155,375— $0283,555SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2022-11-162022-11-183,612$4.49 $16.2K127,586SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2022-08-162022-08-182,234$5.04 $11.3K131,198SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2022-08-162022-08-181,196$5.03 $6.0K133,432SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2022-05-172022-05-19906$5.32 $4.8K133,735SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2022-05-172022-05-192,317$5.32 $12.3K134,641SEC↗
ATRA Atara Biotherapeutics, Inc A Award deriv2022-03-012022-03-0397,398— $097,398SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2022-03-012022-03-031,112$9.86 $11.0K136,958SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2022-03-012022-03-031,465$9.86 $14.4K138,070SEC↗
ATRA Atara Biotherapeutics, Inc A Award2022-03-012022-03-0351,814— $0139,535SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2021-11-162021-11-182,124$17.12 $36.4K87,540SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2021-08-172021-08-192,080$12.53 $26.1K89,664SEC↗
ATRA Atara Biotherapeutics, Inc S Sale2021-05-182021-05-205,681$14.55 $82.7K91,744SEC↗
ATRA Atara Biotherapeutics, Inc A Award deriv2021-03-012021-03-0363,028— $063,028SEC↗
ATRA Atara Biotherapeutics, Inc A Award2021-03-012021-03-0341,756— $097,425SEC↗
ATRA Atara Biotherapeutics, Inc A Award deriv2020-04-202020-04-21110,000— $0110,000SEC↗
ATRA Atara Biotherapeutics, Inc A Award2020-04-202020-04-2155,000— $055,000SEC↗